Washington, D.C…. Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for COVID-19. The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test, a type of test that runs a liquid sample along a surface with reactive molecules. The test detects fragments […]
Los Angeles, CA… As the first doses of the Pfizer vaccine arrive in California, Governor Gavin Newsom today launched “Vaccinate All 58”, California’s campaign for a safe, fair and equitable vaccine for all 58 counties in the state. The Governor joined Kaiser Permanente Los Angeles Medical Center, one of the first locations in the state […]
Albany, NY… Governor Cuomo: “We trust science here in New York. The federal government approved the vaccine. We then had a separate panel that also approved the vaccine and we’ve been following the science all along. I hope this gives you, and the healthcare workers who are battling this every day, a sense of security […]
Washington D.C…. Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. This is the first IGA in an animal that the FDA has approved for both human food consumption and […]
Ames, Iowa… There’s good news for wine and cheese lovers. The foods we eat may have a direct impact on our cognitive acuity in our later years. This is the key finding of an Iowa State University research study spotlighted in an article published in the November 2020 issue of the Journal of Alzheimer’s Disease. […]
New York & Mainz, Germany… Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization (EUA) issued […]
New York & Mainz, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by […]
Washington, DC…The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). In a clinical […]
Washington, DC…Well, good afternoon. We just completed our second meeting this week with members of the White House Coronavirus Task Force. And we’ve continued — we’ve continued to be on the same mission we’ve been on throughout the course of this year, and that is to save American lives and to work every day toward […]
New York, NY & Mainz, DE– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee […]
